About us

Company:          Shinsei Capital Partners, Ltd.

Founded:           April 18, 2018

Management:    CEO         Manabu Nakamura

                           Director   Yoshiyuki Yamakawa (President/Representative Director, HIBIKI Partners)

                           Director   Nobuyuki Hata (Professor, Graduate Institute for Entrepreneurial Studies)

                           Director   Genichi Minowa (CFO, Shinsei Corporate Investment)

                           Auditor    Fuyuki Kojima (Partner attorney, HIFUMI Law)

                           Auditor    Yutaka Kato (Senior Manager, Shinsei Bank Venture Business Division)

Fund:                  New Life Science I Investment Limited Partnership

Founded:           February 7, 2019

Fund Size:         JPY 10.1 billion yen (Final close at February 6, 2020)

GP:                     New Life Science I LLP


July 2004    Shinsei Bank started Pre-IPO investment in Private Equity division

November 2012   Established Shinsei Corporate Investment as a Private Equity  
          investment arm of Shinsei Bank

                              Invested in 76 companies over 14 years from 2004 to 2018, and   
                              26 of which succeeded in IPO

February 2019   Established Shinsei Capital Partners as a carve-out of Life Science 
                              Investment Team in Shinsei Corporate Investment